Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$87.54 -0.42 (-0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) reported Research & Development of $90.53 million for Q2 2026, up 96.5% from $46.07 million a year earlier but down 7.5% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Mirum Pharmaceuticals' Research & Development came in at $282.51 million, up 73.5% year-over-year; for FY2025, it came in at $186.18 million, up 32.4% from FY2024.

  • Research & Development has a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • By year, Research & Development came in at $140.63 million in FY2024 (+37.1%), $102.61 million in FY2023 (-4.0%), $106.84 million in FY2022 (-18.7%) and $131.43 million in FY2021 (+61.1%).
  • Five-year quarterly Research & Development spans a low of $22.01 million in Q2 2023 and a high of $97.91 million in Q1 2026.
  • Year over year, Research & Development has now increased in each of the last ten quarters, with growth averaging 52.3% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q1 2026 (growth of 138.5%); the low point was Q1 2022 (a decline of 36.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $97.91 million (Q1 2026), $51.11 million (Q4 2025) and $42.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Mirum Pharmaceuticals 5.70 Bn 4.11 Bn 145.90 Mn 90.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.53 Mn
Mar 31, 2026 97.91 Mn
Dec 31, 2025 51.11 Mn
Sep 30, 2025 42.96 Mn
Jun 30, 2025 46.07 Mn
Mar 31, 2025 41.04 Mn
Dec 31, 2024 44.03 Mn
Sep 30, 2024 31.71 Mn
Jun 30, 2024 32.67 Mn
Mar 31, 2024 32.22 Mn
Dec 31, 2023 30.94 Mn
Sep 30, 2023 26.12 Mn
Jun 30, 2023 22.01 Mn
Mar 31, 2023 23.55 Mn
Dec 31, 2022 31.11 Mn
Sep 30, 2022 26.22 Mn
Jun 30, 2022 25.43 Mn
Mar 31, 2022 24.09 Mn
Dec 31, 2021 27.78 Mn
Sep 30, 2021 30.47 Mn
API Access

Mirum Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=MIRM&period=max&api_key=YOUR_API_KEY